Technical Analysis for GWPRF - GW Pharmaceuticals plc

Grade Last Price % Change Price Change
grade C 11.78 -6.14% -0.7700
GWPRF closed down 6.14 percent on Friday, August 23, 2019, on 2.02 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical GWPRF trend table...

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Stochastic Reached Oversold Weakness 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 200 DMA Bearish -6.14%
Hammer Candlestick Bullish -6.14%
Cup with Handle Other -6.14%
Narrow Range Bar Range Contraction -6.14%
Gapped Down Weakness -6.14%

Older signals for GWPRF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
GW is a pharmaceutical group developing a portfolio of cannabinoid prescription medicines to meet patient needs in a wide range of therapeutic conditions. GW is licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. The Group's lead programme is the development of a product portfolio of cannabinoid prescription medicines , including Sativex® Oromucosal Spray, to meet patient needs in a wide range of therapeutic indicationsGW has assembled a large in-house team with extensive experience in developing cannabinoids, medicines containing controlled substances, as well as plant-based prescription pharmaceutical products. GW also holds GMP manufacturing licences for the manufacture of pharmaceutical products for both clinical trials and commercial purposes.
Health Pharmaceutical Drugs Pharmacy Pharmaceuticals Policy Medication Pharmaceutical Products Pharmaceutical Sciences Medical Prescription Clinical Pharmacology Cannabinoids Prescription Drug Nabiximols
Is GWPRF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.0
52 Week Low 7.07
Average Volume 3,614
200-Day Moving Average 12.8353
50-Day Moving Average 13.7477
20-Day Moving Average 13.1315
10-Day Moving Average 12.7
Average True Range 0.6346
ADX 9.16
+DI 25.5903
-DI 28.9478
Chandelier Exit (Long, 3 ATRs ) 12.8062
Chandelier Exit (Short, 3 ATRs ) 13.6838
Upper Bollinger Band 14.45
Lower Bollinger Band 11.813
Percent B (%b) -0.01
BandWidth 20.081483
MACD Line -0.408
MACD Signal Line -0.308
MACD Histogram -0.1
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.7850
Resistance 3 (R3) 12.8967 12.6733 12.6175
Resistance 2 (R2) 12.6733 12.4174 12.6175 12.5616
Resistance 1 (R1) 12.2267 12.2593 12.1150 12.1150 12.5058
Pivot Point 12.0033 12.0033 11.9475 11.9475 12.0033
Support 1 (S1) 11.5567 11.7474 11.4450 11.4450 11.0542
Support 2 (S2) 11.3333 11.5893 11.2775 10.9984
Support 3 (S3) 10.8867 11.3333 10.9425
Support 4 (S4) 10.7750